Home/Filings/4/A/0001179110-20-007282
4/A//SEC Filing

Levine Alan M 4/A

Accession 0001179110-20-007282

CIK 0000805928other

Filed

Jun 11, 8:00 PM ET

Accepted

Jun 12, 4:21 PM ET

Size

8.3 KB

Accession

0001179110-20-007282

Insider Transaction Report

Form 4/AAmended
Period: 2020-06-01
Transactions
  • Award

    Stock Option (right to purchase)

    2020-06-01+12,60512,605 total
    Exercise: $9.72Exp: 2030-06-01Common Stock (12,605 underlying)
  • Award

    Restricted Stock Units

    2020-06-01+6,1736,173 total
    Common Stock (6,173 underlying)
Footnotes (3)
  • [F1]Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2021, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
  • [F3]The original Form 4 filed on June 3, 2020, is a duplicate filing. The updated beneficial holdings are being submitted in this Form 4/A.

Documents

1 file

Issuer

Axogen, Inc.

CIK 0000805928

Entity typeother

Related Parties

1
  • filerCIK 0001766833

Filing Metadata

Form type
4/A
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:21 PM ET
Size
8.3 KB